Literature DB >> 3117886

Relative noncovalent association constant between immunoglobulin H and L chains is unrelated to their expression or antigen-binding activity.

P A Hamel1, M H Klein, S J Smith-Gill, K J Dorrington.   

Abstract

With H and L chains derived from the murine hybridoma and myeloma proteins NQ5-89.4, 93G7, AIDA10/3, AIDA10/16, HyHEL-10, HyHEL-9, HyHEL-8, HyHEL-5, XRPC25, J539, UPC10, 6684, and C101, the relationship between the relative affinity between H-L pairs, their antigen-binding characteristics, and the primary structure of their VH and VL domains was assessed. Using competitive chain reassociation assays in which two different L chains were allowed to compete for a limiting amount of an H chain, it was observed that different pairs of L chains tended to compete to the same degree regardless of which H chain was used as the limiting reagent and regardless of whether they were the autologous or heterologous L chain. In agreement with our previous results, it was also observed that when there was limited diversity between the Vk segments of the competing L chains, the relative competitive ability of an L chain was dictated by the nature of the first residue of the Jk segment, residue 96. However, when a high degree of diversity existed between the Vk segments of the competing L chains, the relative affinity was dictated by the V segment. It was further demonstrated that junctional diversity in the L chain may not necessarily be essential for antibody activity, determined using autologous and heterologous, noncovalently reassociated immunoglobulin molecules in antigen-binding assays. Combined with the results of the competitive reassociation assays, it was evident that no correlation between the competitive ability of these L chains existed or, by inference, the relative mutual affinity between different H-L pairs and their ability to form an antigen-binding site. These results were in agreement with the random rearrangement of VH and VL domain gene segments and argue against any restrictions in the expression of the full repertoire of immunoglobulin molecules due to combinatorial (H-L pairing) mechanisms.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3117886

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Heavy and light chain pairing of bivalent quadroma and knobs-into-holes antibodies analyzed by UHR-ESI-QTOF mass spectrometry.

Authors:  Wolfgang Schaefer; Hans R Völger; Stefan Lorenz; Sabine Imhof-Jung; Jörg T Regula; Christian Klein; Michael Mølhøj
Journal:  MAbs       Date:  2015-10-23       Impact factor: 5.857

2.  Antibody redesign by chain shuffling from random combinatorial immunoglobulin libraries.

Authors:  A S Kang; T M Jones; D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

3.  Analyses of recombinant stereotypic IGHV3-21-encoded antibodies expressed in chronic lymphocytic leukemia.

Authors:  Emanuela M Ghia; George F Widhopf; Laura Z Rassenti; Thomas J Kipps
Journal:  J Immunol       Date:  2011-04-27       Impact factor: 5.422

4.  Alternative pathways of disulfide bond formation yield secretion-competent, stable and functional immunoglobulins.

Authors:  Yechiel Elkabetz; Ayala Ofir; Yair Argon; Shoshana Bar-Nun
Journal:  Mol Immunol       Date:  2008-08-09       Impact factor: 4.407

5.  Aggregates, crystals, gels, and amyloids: intracellular and extracellular phenotypes at the crossroads of immunoglobulin physicochemical property and cell physiology.

Authors:  Haruki Hasegawa
Journal:  Int J Cell Biol       Date:  2013-03-05

6.  Receptor editing occurs frequently during normal B cell development.

Authors:  M W Retter; D Nemazee
Journal:  J Exp Med       Date:  1998-10-05       Impact factor: 14.307

7.  Receptor editing: an approach by autoreactive B cells to escape tolerance.

Authors:  D Gay; T Saunders; S Camper; M Weigert
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

8.  NHDL, a recombinant VL/VH hybrid antibody control for IgG2/4 antibodies.

Authors:  Corinna Lau; Martin Berner McAdam; Grethe Bergseth; Algirdas Grevys; Jack Ansgar Bruun; Judith Krey Ludviksen; Hilde Fure; Terje Espevik; Anders Moen; Jan Terje Andersen; Tom Eirik Mollnes
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.